Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: Results from the first feasibility trial

Vox Sanguinis

Volumn 101, Issue 3, 2011, Pages 237-246

  Brauninger, S ^a   Bialleck, H ^a   Thorausch, K ^a   Seifried, E ^a   Bonig, H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Allogeneic; Automatic interface control; Clinical trial; Collection efficiency; Mobilization; Stem cell apheresis

Indexed keywords

APHERESIS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ERYTHROCYTE; FEASIBILITY STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; MEDICAL APPARATUS, EQUIPMENT AND SUPPLIES; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPECTRA OPTIA; VALIDATION STUDY;

ADULT; AUTOMATION; CYTAPHERESIS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS; USER-COMPUTER INTERFACE;

EID: 80052926560     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01484.x     Document Type: Article

References (26)

1. Ballen KK, King RJ, Chitphakdithai P, et al. The national marrow donor program 20years of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14:2-7
2. Gratwohl A, Baldomero H, Schmid O, et al. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transpl 2005; 36:575-590
3. Holig K, Kramer M, Kroschinsky F, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12years of single-center experience in 3928 donors. Blood 2009; 114:3757-3763
4. Anderlini P, Rizzo JD, Nugent ML, et al. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transpl 2001; 27:689-692
5. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344:175-181
6. Cutler C, Antin JH: Peripheral blood stem cells for allogeneic transplantation: a review. Stem Cells 2001; 19:108-117
7. Heuft HG, Dubiel M, Rick O, et al. Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cells in two automated leukapheresis systems. Transfusion 2001; 41:1008-1013
8. Ikeda K, Ohto H, Nemoto K, et al. Collection of MNCs and progenitor cells by two separators for PBPC transplantation: a randomized crossover trial. Transfusion 2003; 43:814-819
9. Ings SJ, Balsa C, Leverett D, et al. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 2006; 134:517-25
10. Reinhardt P, Brauninger S, Bialleck H, et al. Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device. Transfusion 2010; DOI.
11. Arbona C, Prosper F, Benet I, et al. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transpl 1998; 22:39-45
12. Kroger N, Renges H, Kruger W, et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 2000; 111:761-765
13. Kroger N, Sonnenberg S, Cortes-Dericks L, et al. Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study. Transfusion 2004; 44:104-10
14. last accessed 2011-01-28
15. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998; 34:61-70
16. Sutherland DR, Nayyar R, Acton E, et al. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy 2009; 11:595-605
17. Ford CD, Greenwood J, Strupp A, et al. Change in CD34+ cell concentration during peripheral blood progenitor cell collection: effects on collection efficiency and efficacy. Transfusion 2002; 42:904-911
18. Haylock DN, Canty A, Thorp D, et al. A discrepancy between the instantaneous and the overall collection efficiency of the Fenwal CS3000 for peripheral blood stem cell apheresis. J Clin Apher 1992; 7:6-11
19. Cooling L, Hoffmann S, Herrst M, et al. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma. Transfusion 2010; 50:100-119
20. Bolan CD, Leitman SF: Management of anticoagulation-associated toxicity during large-volume leukapheresis of peripheral blood stem cell donors. Blood 2002; 99:1878
21. Anderlini P, Donato M, Chan KW, et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999; 39:555-560
22. Benjamin RJ, Linsley L, Fountain D, et al. Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion 1997; 37:79-85
23. Anderlini P, Korbling M, Dale D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997; 90:903-908
24. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) [Guidelines for production of blood and blood components and use of blood products]. Köln, Deutscher Ärzte-Verlag; 2008
25. Cassens U, Barth IM, Baumann C, et al. Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes. Transfusion 2004; 44:1593-1602
26. Smolowicz AG, Villman K, Tidefelt U: Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 1997; 37:188-192